Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Screening for artificial microRNA that enhance oncolytic viruses in pancreatic cancer models

EF 2014-15

Résumé
Pancreatic carcinoma (PCa) is currently one of the most lethal types of cancer which has a less than 5% five year survival rate and most patients do not survive more than six months after diagnosis. PCa tumours are made up of not only cancer cells but also fibrotic cells causing these tumours to be extremely difficult to treat. Therefore, it is clear that a successful therapeutic for PCa would need to target these fibrotic cells. Oncolytic viruses (OVs) have emerged as a promising cancer therapeutic. Unlike radiation and chemotherapy, OVs are developed to destroy cancerous cells but not healthy tissue. However, they are not designed to target the fibrotic cells like those found in PCa. A recent study has determined that these fibrotic cells are a lot more susceptible to OVs than healthy cells, however not nearly as much as cancer cells. Therefore, we propose to design OVs that will be able to destroy both the cancerous and fibrotic cells found in PCa. A new method to determine artificial microRNA (amiRNA) that can enhance virus replication in specific models has recently been published by Dr. Benjamin TenOever et al. amiRNA are small molecules that can specifically regulate genes. This method is done by infecting mice with a pool of viruses that each expresses a unique amiRNA. A next set of mice is then infected with the new amiRNA virus pool isolated from the previous set. This is repeated several times and selects for amiRNA that best enhance viral replication. We suggest using the same method to determine amiRNA that aid OVs to replicate in and destroy the cancer cells and the fibrotic tissue found in PCa tumours. In addition, the determination of the genes regulated by these amiRNA could also be crucial in finding weaknesses in PCa that can be exploited by future OVs.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331448
Name
Boileau Meaghan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Screening for artificial microRNA that enhance oncolytic viruses in pancreatic cancer models
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Artificial Microrna (Amirna); Cancer Associated Fibroblasts; Oncolytic Viruses; Pancreatic Cancer; Rhabdoviruses; Tumour Microenvironment
Abstract
Pancreatic carcinoma (PCa) is currently one of the most lethal types of cancer which has a less than 5% five year survival rate and most patients do not survive more than six months after diagnosis. PCa tumours are made up of not only cancer cells but also fibrotic cells causing these tumours to be extremely difficult to treat. Therefore, it is clear that a successful therapeutic for PCa would need to target these fibrotic cells. Oncolytic viruses (OVs) have emerged as a promising cancer therapeutic. Unlike radiation and chemotherapy, OVs are developed to destroy cancerous cells but not healthy tissue. However, they are not designed to target the fibrotic cells like those found in PCa. A recent study has determined that these fibrotic cells are a lot more susceptible to OVs than healthy cells, however not nearly as much as cancer cells. Therefore, we propose to design OVs that will be able to destroy both the cancerous and fibrotic cells found in PCa. A new method to determine artificial microRNA (amiRNA) that can enhance virus replication in specific models has recently been published by Dr. Benjamin TenOever et al. amiRNA are small molecules that can specifically regulate genes. This method is done by infecting mice with a pool of viruses that each expresses a unique amiRNA. A next set of mice is then infected with the new amiRNA virus pool isolated from the previous set. This is repeated several times and selects for amiRNA that best enhance viral replication. We suggest using the same method to determine amiRNA that aid OVs to replicate in and destroy the cancer cells and the fibrotic tissue found in PCa tumours. In addition, the determination of the genes regulated by these amiRNA could also be crucial in finding weaknesses in PCa that can be exploited by future OVs.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boileau, Meaghan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~